# Silvia, Inc.: financial statements, quarterly

SVIA · Nasdaq · CIK 2076163 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/svia.md) · [Financials](/companies/svia/financials.md) · [Filings](/companies/svia/filings.md) · [Insiders](/companies/svia/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/svia/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: |
| Revenue | $m | not reported | [0.0](/filings/0001493152-26-023070.md) | [0.0](/filings/0001493152-26-037756.md) |
| Operating income | $m | [(0.3)](/filings/0001213900-25-120765.md) | [(7.6)](/filings/0001493152-26-023070.md) | [(15.0)](/filings/0001493152-26-037756.md) |
| Interest expense | $m | not reported | [1.1](/filings/0001493152-26-023070.md) | [0.8](/filings/0001493152-26-037756.md) |
| Income tax | $m | not reported | [0.2](/filings/0001493152-26-023070.md) | [(2.5)](/filings/0001493152-26-037756.md) |
| Net income | $m | [(0.3)](/filings/0001213900-25-120765.md) | [(108)](/filings/0001493152-26-023070.md) | [(65.0)](/filings/0001493152-26-037756.md) |
| Diluted EPS | $ per share | [319048.00](/filings/0001213900-25-120765.md) | [(1.30)](/filings/0001493152-26-023070.md) | [(0.73)](/filings/0001493152-26-037756.md) |
| Basic EPS | $ per share | [(319048.00)](/filings/0001213900-25-120765.md) | [(1.30)](/filings/0001493152-26-023070.md) | [(0.73)](/filings/0001493152-26-037756.md) |

- Revenue: us-gaap:Revenues
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | period not labelled (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | not reported | [45.0](/filings/0001493152-26-007352.md) | [26.0](/filings/0001493152-26-023070.md) | not reported |
| Current assets | $m | not reported | not reported | [197](/filings/0001493152-26-037756.md) | [27.6](/filings/0001493152-26-023070.md) | [17.0](/filings/0001493152-26-037756.md) |
| Total assets | $m | not reported | not reported | [639](/filings/0001493152-26-037756.md) | [402](/filings/0001493152-26-023070.md) | [358](/filings/0001493152-26-037756.md) |
| Current liabilities | $m | not reported | [0.3](/filings/0001213900-25-120765.md) | [2.3](/filings/0001493152-26-037756.md) | [2.1](/filings/0001493152-26-023070.md) | [94.3](/filings/0001493152-26-037756.md) |
| Total liabilities | $m | not reported | [0.3](/filings/0001213900-25-120765.md) | [219](/filings/0001493152-26-037756.md) | [94.6](/filings/0001493152-26-023070.md) | [95.7](/filings/0001493152-26-037756.md) |
| Shareholders' equity | $m | [485](/filings/0001493152-26-037756.md) | [(0.3)](/filings/0001213900-25-120765.md) | [420](/filings/0001493152-26-037756.md) | [307](/filings/0001493152-26-037756.md) | [263](/filings/0001493152-26-037756.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2025 (2025-09-30) | Q2 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(0.1)](/filings/0001213900-25-120765.md) | [(7.4) d](/filings/0001493152-26-007352.md) | [(3.3)](/filings/0001493152-26-023070.md) | [(11.3) d](/filings/0001493152-26-037756.md) |
| Capital expenditure | $m | not reported | not reported | [0.2](/filings/0001493152-26-023070.md) | [0.2 d](/filings/0001493152-26-037756.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

## Shares

| Line item | Unit | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [0.0](/filings/0001213900-25-120765.md) | [82.9](/filings/0001493152-26-023070.md) | [89.4](/filings/0001493152-26-037756.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 88,369,575 at 2026-08-11, from the cover of the [10-Q filed 2026-08-13](/filings/0001493152-26-037756.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:51 ET. No prices; not investment advice.